CDKN2A and Patent ductus arteriosus: Massive sequencing studies have shown the heterogeneity and complexity of PDA molecular alterations beside the classical four: KRAS, CDKN2A, SMAD4 and TP53. These include less prevalent mutations, changes in copy number and chromosomic alterations as a consequence of genome instability and genome doubling.